Drug recall · February 5, 2014
BuPROPion Hydrochloride Extended-Release Tablet recall
Why: Failed Dissolution Specifications: Failed stability testing for dissolution test at 18 months.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
BuPROPion Hydrochloride Extended-Release Tablet (XL) 150mg, Rx only, a) 30 count bottle(NDC 0591-3331-30), b) 90 count bottle (NDC 0591-3331-19), c) 500 count bottle (NDC 0591-3331-05), Manufactactred By: Watson Laboratories, Inc. Corona, CA 92880
- Lots / codes
Lots: 524099M, 524100A, 521687A
- Quantity
- 139,944 bottles
- Company
- Actavis Inc, Parsippany, NJ
- Distribution
- Nationwide and Puerto Rico
- Initiated
- November 15, 2013 · Voluntary: Firm initiated
- Classified
- January 29, 2014
- Reported
- February 5, 2014
- Ended
- June 16, 2015
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Bupropion
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.